Logo image of ANPC

ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Stock Analyst Ratings

USA - NASDAQ:ANPC - US03635R2067 - ADR

4.37 USD
-0.25 (-5.41%)
Last: 5/19/2023, 8:11:20 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to ANPC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 86.73% above the current price.
ANPC was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ANPC.
In the previous month the buy percentage consensus was at a similar level.
ANPC was analyzed by 7 analysts. More opinions would make the average more meaningful.
ANPC Historical Analyst RatingsANPC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 4.378.088.168.168.40 - 84.90% 86.73% 86.73% 92.22%
ANPC Current Analyst RatingANPC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

ANPAC BIO-MEDICAL SCIENC-ADR / ANPC FAQ

What is the price target for ANPC stock?

7 analysts have analysed ANPC and the average price target is 8.16 USD. This implies a price increase of 86.73% is expected in the next year compared to the current price of 4.37.


How do analysts rate ANPAC BIO-MEDICAL SCIENC-ADR (ANPC)?

The consensus rating for ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.